Latest Intellectual Property News

Algorae Pharmaceuticals has independently validated its AlgoraeOS v2 platform, confirming improved accuracy in predicting synergistic drug combinations involving CBD across cancer models.

Alcoa Corporation has struck a $4.1 billion deal to acquire South32's bauxite, alumina, and aluminium operations, including a contingent value right of up to $750 million tied to commodity prices. The transaction is expected to close in H1 2027, pending approvals.

Wide Open Agriculture is closing its German plant and pivoting to contract manufacturing in Asia to cut costs and scale lupin ingredient production efficiently under new CEO Craig Swan.

Island Pharmaceuticals has strengthened its intellectual property portfolio with a Singapore patent covering ISLA-101 for flavivirus infections, including Dengue and Chikungunya, extending commercial exclusivity to 2034 in a key Asia-Pacific market.

Neurotech International has received Notices of Allowance from the USPTO for two patents covering its lead drug NTI164, reinforcing its intellectual property position as it advances Phase 3 trials for autism spectrum disorder.

Echo IQ has locked in a pivotal exclusive data licensing deal with Advara HeartCare, gaining access to as many as one million de-identified echocardiography studies, a move set to turbocharge its cardiovascular AI development.

Critical Resources Limited has secured independent peer-reviewed validation of its dry supersonic deposition (DSD) cathode technology, confirming a solvent- and binder-free process with promising durability and capacity metrics. This milestone strengthens its licensing prospects as the company advances toward full solid-state battery integration.

Nanoveu has completed its acquisition of Singapore’s Spinoff Robotics, gaining validated drone platforms and engineering talent to fast-track its ECS-DoT edge-AI silicon integration for advanced aerial applications.

Mesoblast has received a Biologics License Application filing number from the FDA for rexlemestrocel-L, targeting life-threatening bleeding in end-stage heart failure patients with LVADs, advancing its regulatory journey with orphan drug and RMAT designations.

Archer Materials has secured a three-year strategic deal with IonQ, the global quantum computing leader, gaining access to advanced quantum cloud services and exploring onshore deployment of quantum hardware in Australia.

Strategic Elements has achieved a significant milestone with the granting of a patent in Japan for its Energy Ink™ moisture energy platform, reinforcing its foothold in a critical electronics market and advancing its battery-free device ambitions.

CONNEQT Health Limited is offering eligible shareholders a share purchase plan to raise up to $0.5 million at a 24.3% discount, aiming to fund its next growth phase in vascular health technology.